References
- Wilkinson R.J., Llewelyn M., Toossi Z., Patel P., Pasvol G., Lalvani A., et al.. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet. 2000;355:618–621.
- Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al.. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–1773.
- Martineau A.R., Timms P.M., Bothamley G.H., Hanifa Y., Islam K., Claxton A.P., et al.. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377:242–250.
- Coussens A.K., Wilkinson R.J., Hanifa Y., Nikolayevskyy V., Elkington P.T., Islam K., et al.. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences of the United States of America. 2012;109:15449–54.
- Lalvani A, Behr M.A., Sridhar S. Innate immunity to TB: a druggable balancing act. Cell. 2012;148:389–91.
- Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. The Journal of Steroid Biochemistry and Molecular Biology. 2007;103:793–8.
- Ganmaa D, Giovannucci E., Bloom B.R., Fawzi W., Burr W., Batbaatar D., et al.. Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. The American Journal of Clinical Nutrition. 2012;96:391–6.